Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Infect Dis (Lond). 2019 Apr 15;51(6):446–451. doi: 10.1080/23744235.2019.1593499

Figure 1.

Figure 1.

Biofilm formation in the in 96-well plate crystal violet assay (a) and viability after 24 h exposure to rifampicin, measured with XTT assay (b) of representative ‘strong’ and ‘weak’ biofilm-forming S. aureus strains from the invasive isolate collection. P values calculated with the unpaired t test.